Skip to main content
OpenTrials

Clinical trial condition

Epilepsy, Generalized

Explore clinical trials studying Epilepsy, Generalized. Study availability and eligibility vary by location and protocol.

137 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Epilepsy, Generalized trial results

Enrolling by invitation

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

NCT06908226

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Austin Hospital Heidelberg, Victoria, Australia
  • Instituto de Neurologia de Curitiba (INC) Curitiba, Paraná, Brazil
  • Hôpital Roger Salengro Lille, Nord, France
  • AP-HM- Hôpital de La Timone Marseille, France
View all 83 locations
View Trial Details
Enrolling by invitation

Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

NCT07287163

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +9 more
Locations
  • Praxis Research Site Miami Lakes, Florida, United States
  • Praxis Research Site Naples, Florida, United States
  • Praxis Research Site Lafayette, Louisiana, United States
  • Praxis Research Site Bethesda, Maryland, United States
View all 36 locations
View Trial Details
Active, not recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

NCT06660394

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +11 more
Locations
  • Austin Hospital Heidelberg, Victoria, Australia
  • Instituto de Neurologia de Curitiba (INC) Curitiba, Paraná, Brazil
  • Hôpital Roger Salengro Lille, Nord, France
  • AP-HP - Hôpital universitaire Robert-Debré Paris, France
View all 105 locations
View Trial Details
Active, not recruiting

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322

Conditions
Brain Diseases, Central Nervous System Diseases, Childhood Absence Epilepsy, +6 more
Locations
  • Ep0224 50140 Birmingham, Alabama, United States
  • Ep0224 50638 New Brunswick, New Jersey, United States
  • Ep0224 50640 Winston-Salem, North Carolina, United States
  • Ep0224 20321 Tbilisi, Georgia
View Trial Details
Active, not recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site Downey, California, United States
  • Clinical Trial Site Long Beach, California, United States
  • Clinical Trial Site Sacramento, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details

Related conditions